Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-(D-Carboxybutyl)-L-homocysteine is a synthetic small molecule and an analog of homocysteine, classified as an alpha amino acid. It acts as a bisubstrate analog inhibitor of betaine-homocysteine S-methyltransferase (BHMT), an enzyme involved in the methylation of homocysteine to methionine using betaine as a methyl donor. By mimicking both substrates, this compound binds to BHMT and induces conformational changes that can protect the enzyme from oxidative inactivation or serve as a tool for studying enzyme mechanism and structure. It is primarily used experimentally in biochemical research rather than clinical settings[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-(D-Carboxybutyl)-L-homocysteine.